ESG

• 09March

  Participation in the Cell Therapy Manufa...

  Dr. Hsiu-Ling Hsiao(CSO) had be invited to participate as a speaker and lead discussion at...

• 08February

  FDA APPROVAL FOR A CLINICAL PHASE I TRIA...

  FDA APPROVAL FOR A CLINICAL PHASE I TRIAL WITH ITS NEW MYOCARDIAL INFARCTION DRUG